Lansing – October 16, 2026 -- Niowave is building an 80,000-square-foot medical radioisotope production facility in Lansing, Michigan, with a capital investment of more than $85 million and operations expected to start in 2028.

Labor Secretary Keith Sonderling toured Niowave's existing dedicated production facility and the construction site of its second plant. He also held a roundtable with company leaders on the production of medical radioisotopes for cancer treatments.